An interventional study of Stellate nerve block in Stellate Ganglion Block, sponsored by Yangzhou University. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-22.
Sponsored by Yangzhou University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Post-operative new-onset atrial fibrillation (POAF) is one of the most common arrhythmias in adults after direct intracardiac surgery with extracorporeal circulation. The incidence of POAF in coronary artery bypass grafting (CABG) is approximately 30%. POAF can lead to an increased risk of complications such as stroke, heart failure, and acute kidney injury, which not only prolongs the patient's hospital stay, but also increases hospital costs and mortality. operation, extracorporeal circulation, and the patient's underlying conditions (such as age, gender, hypertension, and diabetes), which cause sympathetic activation, inflammatory response, and myocardial ischemia in the organism. The stellate ganglion block (SGB) regulates the sympathetic tone of the innervated nerves and thus the autonomic function of the body. SGB can effectively regulate the sympathetic-parasympathetic imbalance. Also, SGB may exert some anti-inflammatory effects. In this study, ultrasound-guided SGB was used in CABG patients to investigate its effect on the occurrence of POAF.
42 studies on the registry are indexed under Ganglion Cysts; 7 are open to participants now.
This study's enrollment of 108 is above the median of 62 across 31 interventional studies indexed under Ganglion Cysts.
Browse Ganglion Cysts studies →Yangzhou University is the lead sponsor of 41 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Left stellate ganglion block under ultrasound guidance was administered with 0.375% Ropivacaine hydrochloride 5 ml
Procedure: Stellate nerve block
do nothing
Before the operation, the left stellate ganglion block was performed, and 0.375% ropivacaine 5ml was injected into the stellate ganglion.
The occurrence of new atrial fibrillation was detected by ECG monitoring
ECG monitor shows atrial fibrillation. To be specific: 1)Irregular R-R interval (when atrioventricular conduction is present), 2) P wave disappearance, 3) irregular atrial activity.
Time frame: Within 5 days after surgery
AF burden
The percentage of the time during which atrial fibrillation occurs in the overall recorded time.
Time frame: within 5 days after surgery
Duration of the first episode of POAF
The duration from the onset to the resolution of the first atrial fibrillation after surgery.
Time frame: within 5 days after surgery
Need for Antiarrhythmic treatments
Record the types of medications used and whether electrical cardioversion has been used.
Time frame: within 5 days after the operation
the concentration of interleukin-6
Interleukin-6 (IL-6) is an important cytokine that plays a key role in immune responses, inflammation, and tumor development.
Time frame: end of surgery, 24 hour postoperatively, 72hour postoperatively, 5 day postoperatively
the concentration of CRP
C-reactive protein (CRP) is a protein produced by the liver that is mainly used to indicate the presence of inflammation in the body.
Time frame: end of surgery,24 hour postoperatively ,72 hour postoperatively ,5 day postoperatively
Changes of intraoperative Left ventricular diastolic function
Left ventricular diastolic function were measured by transesophageal echocardiography (TEE)
Time frame: T1 (after sternotomy and before CPB) and T2 (30 minute after CPB cessation).
the concentration of Hs-cTnT
hs-cTnT is an important biomarker used for detecting cardiac injury.
Time frame: end of surgery, 24hour postoperatively, 72hour postoperatively
the concentration of CK-MB
CK-MB is an enzyme primarily found in cardiac muscle cells. Its concentration is commonly used to assess cardiac damage, especially in the case of myocardial infarction
Time frame: end of surgery, 24hour postoperatively, 72hour postoperatively
postoperative adverse reactions
Record the occurrence of adverse reactions postoperative
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Ran from Jun 2023 to primary completion in Jun 2024, 12 months.
Of 16 interventional studies with no phase under Ganglion Cysts, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 26. This study's 12 months is close to that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yangzhou University